Synaptic plasticity, dopamine and Parkinson's disease: one step ahead.
Calabresi
Paolo
P
calabre@unipg.it
Mercuri
Nicola Biagio
NB
Di Filippo
Massimiliano
M
D000978:Antiparkinson Agents / Q000627:therapeutic use; D001479:Basal Ganglia / Q000378:metabolism*; D046690:Deep Brain Stimulation; D004298:Dopamine / Q000502:physiology*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D009473:Neuronal Plasticity / Q000187:drug effects*; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism* / Q000628:therapy; D015398:Signal Transduction / Q000502:physiology*; D013378:Substantia Nigra / Q000378:metabolism
D000978:Antiparkinson Agents; D007980:Levodopa; D004298:Dopamine